medcelerator · clinician one-pager
New Oral Antibiotic for Complicated Urinary Tract Infections
Utebzi (tebipenem pivoxil) — first oral carbapenem for adults with complicated UTI
FDA Approved · United States · September 7, 2026
Condition: Complicated Urinary Tract Infection
Who this is for
Utebzi (tebipenem pivoxil) is the first carbapenem antibiotic pill approved in the United States. It treats complicated urinary tract infections, including kidney infections, in adults with few other pill options.
Next clinical step
The US Food and Drug Administration (FDA) has approved this medicine. In the United States, ask your doctor or a specialist whether it suits you. They can write a prescription. Insurance or public drug plan coverage is not guaranteed.
Ways to access this treatment
United States · Prescription
US prescription (FDA-labelled)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215960Origs000lbl.pdf
General resources for further research
ClinicalTrials.gov
US National Library of Medicine registry of clinical studies. Search by condition, drug, NCT number, and location. A listing is not enrolment, eligibility, or funding. Talk with the trial contact and a clinician before assuming a slot exists.
https://clinicaltrials.gov/
AI-produced discussion aid; not prescribing instructions. Approval does not establish coverage. Full article: https://medcelerator.com/articles/utebzi-tebipenem